LEXICON PHARMACEUTICALS ($LXRX) posted quarterly earnings results for Q4 2025 on Thursday, March 5th. The company reported earnings of -$0.04 per share, beating estimates of -$0.07 by $0.03. The company also reported revenue of $5,490,000, beating estimates of $3,204,432 by $2,285,568.
You can see Quiver Quantitative's $LXRX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LEXICON PHARMACEUTICALS Insider Trading Activity
LEXICON PHARMACEUTICALS insiders have traded $LXRX stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LXRX stock by insiders over the last 6 months:
- GLOBAL MANAGEMENT, LLC INVUS purchased 1,538,462 shares for an estimated $2,000,000
- RAYMOND DEBBANE has made 4 purchases buying 252,000 shares for an estimated $369,735 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LEXICON PHARMACEUTICALS Hedge Fund Activity
We have seen 52 institutional investors add shares of LEXICON PHARMACEUTICALS stock to their portfolio, and 73 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 2,654,315 shares (+752.1%) to their portfolio in Q4 2025, for an estimated $3,052,462
- JANE STREET GROUP, LLC added 1,267,774 shares (+277.7%) to their portfolio in Q4 2025, for an estimated $1,457,940
- MARSHALL WACE, LLP added 1,262,367 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,451,722
- MILLENNIUM MANAGEMENT LLC added 991,073 shares (+25.9%) to their portfolio in Q4 2025, for an estimated $1,139,733
- CITADEL ADVISORS LLC removed 923,052 shares (-35.0%) from their portfolio in Q4 2025, for an estimated $1,061,509
- GOLDMAN SACHS GROUP INC added 861,857 shares (+1452.2%) to their portfolio in Q4 2025, for an estimated $991,135
- FMR LLC removed 845,541 shares (-2.2%) from their portfolio in Q4 2025, for an estimated $972,372
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
